{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:59:19Z","timestamp":1794614359265,"version":"4.9.1"},"reference-count":119,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:p>Tuberculosis (TB) remains an important problem among children in the United States and throughout the world. There is no diagnostic reference standard for latent tuberculosis infection (also referred to as tuberculosis infection [TBI]). The tuberculin skin test (TST) has many limitations, including difficulty in administration and interpretation, the need for a return visit by the patient, and false-positive results caused by cross-reaction with Mycobacterium bovis\u2013bacille Calmette-Guerin vaccines and many nontuberculous mycobacteria. Interferon-gamma release assays (IGRAs) are blood tests that use antigens specific for M tuberculosis; as a result, IGRAs yield fewer false-positive results than the TST. Both IGRAs and the TST have reduced sensitivity in immunocompromised children, including children with severe TB disease. Both methods have high positive predictive value when applied to children with risk factors for TBI, especially recent contact with a person who has TB disease. The advantages of using IGRAs and diminished experience with the placement and interpretation of the TST favor expanded use of IGRAs in children in the United States. There are now several effective and safe regimens for the treatment of TBI in children. For improved adherence to therapy, the 3 rifamycin-based regimens are preferred because of their short duration. Daily isoniazid can be used if there is intolerance or drug interactions with rifamycins. A TB specialist should be involved when there are questions regarding testing interpretation, selection of an appropriate treatment regimen, or management of adverse effects.<\/jats:p>","DOI":"10.1542\/peds.2021-054663","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T01:06:38Z","timestamp":1638147998000},"source":"Crossref","is-referenced-by-count":84,"title":["Tuberculosis Infection in Children and Adolescents: Testing and Treatment"],"prefix":"10.1542","volume":"148","author":[{"given":"Dawn","family":"Nolt","sequence":"first","affiliation":[{"name":"aDepartment of Pediatrics, Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Starke","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","reference":[{"issue":"11","key":"2024072415162209600_B1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15585\/mmwr.mm6911a3","article-title":"Tuberculosis - United States, 2019","volume":"69","author":"Schwartz","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2024072415162209600_B2","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1016\/S2468-2667(19)30134-3","article-title":"Epidemiology of tuberculosis among children and adolescents in the USA, 2007-17: an analysis of national surveillance data","volume":"4","author":"Cowger","year":"2019","journal-title":"Lancet Public Health"},{"issue":"1","key":"2024072415162209600_B3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2024072415162209600_B4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/resp.12483","article-title":"T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts","volume":"20","author":"Leung","year":"2015","journal-title":"Respirology"},{"issue":"10","key":"2024072415162209600_B5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-\u03b3 release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2024072415162209600_B6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5588\/ijtld.17.0718","article-title":"Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea","volume":"22","author":"Sohn","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"2024072415162209600_B7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/0009922813515743","article-title":"Relationship between tuberculin skin test (TST) size and interferon gamma release assay (IGRA) result: when should clinicians obtain IGRAs in children with positive TSTs?","volume":"53","author":"Cruz","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"2024072415162209600_B8","first-page":"e2020200013","article-title":"2020 Recommendations for preventive pediatric health care","volume":"145","author":"American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Working Group","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"2024072415162209600_B9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2024072415162209600_B10","doi-asserted-by":"crossref","first-page":"e20191930","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-\u03b3 release assays in children &lt;15 years of age","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics"},{"issue":"3","key":"2024072415162209600_B11","doi-asserted-by":"crossref","first-page":"e0213304","DOI":"10.1371\/journal.pone.0213304","article-title":"Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis","volume":"14","author":"Nguyen","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"2024072415162209600_B12","doi-asserted-by":"crossref","first-page":"e0143820","DOI":"10.1371\/journal.pone.0143820","article-title":"Performance of the interferon gamma release assays in tuberculosis disease in children five years old or less","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"2024072415162209600_B13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2024072415162209600_B14","first-page":"829","article-title":"Tuberculosis","volume-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2018"},{"issue":"4","key":"2024072415162209600_B15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2024072415162209600_B16","first-page":"49","article-title":"Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects","volume":"47","author":"Horwitz","year":"1972","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2024072415162209600_B17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/infdis\/174.1.113","article-title":"Immune responses stimulated by percutaneous and intradermal bacille Calmette-Gu\u00e9rin","volume":"174","author":"Kemp","year":"1996","journal-title":"J Infect Dis"},{"issue":"4","key":"2024072415162209600_B18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1542\/peds.36.4.624","article-title":"The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children","volume":"36","author":"Lifschitz","year":"1965","journal-title":"Pediatrics"},{"issue":"2","key":"2024072415162209600_B19","first-page":"127","article-title":"Interpretation of the PPD skin test in BCG-vaccinated children","volume":"113","author":"Joncas","year":"1975","journal-title":"Can Med Assoc J"},{"issue":"10","key":"2024072415162209600_B20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thoraxjnl-2015-207687","article-title":"The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection","volume":"71","author":"Seddon","year":"2016","journal-title":"Thorax"},{"issue":"1","key":"2024072415162209600_B21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2024072415162209600_B22","first-page":"578","article-title":"Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Gu\u00e9rin at birth in Santiago, Chile","volume":"7","author":"Sepulveda","year":"1988","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"2024072415162209600_B23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","article-title":"Evaluating latent tuberculosis infection diagnostics using latent class analysis","volume":"73","author":"Stout","year":"2018","journal-title":"Thorax"},{"issue":"6","key":"2024072415162209600_B24","doi-asserted-by":"crossref","first-page":"e20183327","DOI":"10.1542\/peds.2018-3327","article-title":"The case for retiring the tuberculin skin test","volume":"143","author":"Cruz","year":"2019","journal-title":"Pediatrics"},{"issue":"2","key":"2024072415162209600_B25","doi-asserted-by":"crossref","first-page":"e01360-17","DOI":"10.1128\/JCM.01360-17","article-title":"Quantitative analysis of gamma interferon release assay response in children with latent and active tuberculosis","volume":"56","author":"Lombardi","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2024072415162209600_B26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12185-014-1504-3","article-title":"An indeterminate result of QuantiFERON-TB Gold In-Tube for miliary tuberculosis due to a high level of IFN-\u03b3 production","volume":"99","author":"Hangai","year":"2014","journal-title":"Int J Hematol"},{"issue":"RR-5","key":"2024072415162209600_B27","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"2024072415162209600_B28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/657336","article-title":"Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers","volume":"31","author":"Gandra","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"2024072415162209600_B29","doi-asserted-by":"crossref","first-page":"e47340","DOI":"10.1371\/journal.pone.0047340","article-title":"Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing","volume":"7","author":"Nkurunungi","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2024072415162209600_B30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2024072415162209600_B31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024072415162209600_B32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tube.2018.03.002","article-title":"Seasonal variation in the performance of QuantiFERON-TB Gold In-Tube assays used for the diagnosis of tuberculosis infection","volume":"110","author":"Tebruegge","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"2024072415162209600_B33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5588\/ijtld.17.0650","article-title":"Paradox of serial interferon-gamma release assays: variability width more important than specificity size","volume":"22","author":"Stout","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"2024072415162209600_B34","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/INF.0000000000001732","article-title":"Optimizing blood collection and processing for Quantiferon-TB Gold in-Tube testing gives low rates of indeterminate results: clinical implications","volume":"37","author":"Kordy","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2024072415162209600_B35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2024072415162209600_B36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"2024072415162209600_B37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1574-695X.2011.00838.x","article-title":"Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis","volume":"63","author":"Sun","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"3","key":"2024072415162209600_B38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/039463201202500301","article-title":"Interferon-\u03b3 release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis","volume":"25","author":"Chiappini","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"2024072415162209600_B39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cix745","article-title":"QuantiFERON-TB Gold In-Tube as a confirmatory test for tuberculin skin test in tuberculosis contact tracing: a noninferiority clinical trial","volume":"66","author":"Mu\u00f1oz","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"17","key":"2024072415162209600_B40","doi-asserted-by":"crossref","first-page":"e3470","DOI":"10.1097\/MD.0000000000003470","article-title":"Evaluation of the immune response to interferon gamma release assay and tuberculin skin test among BCG vaccinated children in east of Egypt: a cross-sectional study","volume":"95","author":"Beshir","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024072415162209600_B41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tmaid.2018.07.009","article-title":"Utility of tuberculin skin test and IGRA for tuberculosis screening in internationally adopted children: retrospective analysis from a single center in Florence, Italy","volume":"28","author":"Mastrolia","year":"2019","journal-title":"Travel Med Infect Dis"},{"issue":"8","key":"2024072415162209600_B42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/jpc.13865","article-title":"Tuberculin skin test versus interferon-gamma release assay in refugee children: a retrospective cohort study","volume":"54","author":"Elliot","year":"2018","journal-title":"J Paediatr Child Health"},{"issue":"6","key":"2024072415162209600_B43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/INF.0000000000000680","article-title":"Tuberculin skin testing and T-SPOT.TB in internationally adopted children","volume":"34","author":"Spicer","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2024072415162209600_B44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.2007-3618","article-title":"Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test","volume":"123","author":"Lighter","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"2024072415162209600_B45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jpids\/piu024","article-title":"Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic","volume":"4","author":"Rose","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"2024072415162209600_B46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diagmicrobio.2008.08.022","article-title":"The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Gu\u00e9rin vaccinated children","volume":"62","author":"Chun","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"2024072415162209600_B47","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/INF.0b013e318269d10c","article-title":"Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis","volume":"31","author":"Ling","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2024072415162209600_B48","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201707-1487OC","article-title":"Evaluating UK national guidance for screening of children for tuberculosis. A prospective multicenter study","volume":"197","author":"Kampmann","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2024072415162209600_B49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/INF.0000000000000986","article-title":"High discordance between pre-US and post-US entry tuberculosis test results among immigrant children: is it time to adopt interferon gamma release assay for preentry tuberculosis screening?","volume":"35","author":"Lowenthal","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2024072415162209600_B50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12879-016-1872-9","article-title":"Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with \u201cpositive\u201d tuberculin skin test (\u226510\u00a0mm)","volume":"16","author":"Gudj\u00f3nsd\u00f3ttir","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2024072415162209600_B51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3345\/kjp.2016.59.6.256","article-title":"Usefulness of interferon-\u03b3 release assay for the diagnosis of latent tuberculosis infection in young children","volume":"59","author":"Yun","year":"2016","journal-title":"Korean J Pediatr"},{"issue":"9","key":"2024072415162209600_B52","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2012-203086","article-title":"Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis","volume":"68","author":"Ling","year":"2013","journal-title":"Thorax"},{"issue":"3","key":"2024072415162209600_B53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00431-013-2161-x","article-title":"The sensitivity of an interferon-\u03b3 release assay in microbiologically confirmed pediatric tuberculosis","volume":"173","author":"Schopfer","year":"2014","journal-title":"Eur J Pediatr"},{"key":"2024072415162209600_B54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12879-016-1461-y","article-title":"Performance of interferon-\u03b3 release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis","volume":"16","author":"Laurenti","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2024072415162209600_B55","doi-asserted-by":"crossref","first-page":"e20173918","DOI":"10.1542\/peds.2017-3918","article-title":"Interferon-\u03b3 release assay performance for tuberculosis in childhood","volume":"141","author":"Kay","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"2024072415162209600_B56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/INF.0000000000001350","article-title":"Quantiferon-TB Gold In-Tube improves tuberculosis diagnosis in children","volume":"36","author":"Petrucci","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2024072415162209600_B57","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1542\/peds.2005-2095","article-title":"Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis","volume":"117","author":"Hill","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"2024072415162209600_B58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/INF.0b013e3181cb45da","article-title":"Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia","volume":"29","author":"Adetifa","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2024072415162209600_B59","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/INF.0b013e3181a16394","article-title":"The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status","volume":"28","author":"Haustein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"2024072415162209600_B60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/INF.0b013e31819abf6b","article-title":"Interferon-gamma release assay improves the diagnosis of tuberculosis in children","volume":"28","author":"Bianchi","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2024072415162209600_B61","doi-asserted-by":"crossref","unstructured":"Cruz\n              AT\n            , GeltemeyerAM, StarkeJR, FloresJA, GravissEA, SmithKC. Comparing the tuberculin skin test and T-SPOT.TB blood test in children. Pediatrics. 2011;127(1). Available at: www.pediatrics.org\/cgi\/content\/full\/127\/1\/e31","DOI":"10.1542\/peds.2010-1725"},{"issue":"4","key":"2024072415162209600_B62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/INF.0000000000001792","article-title":"T-SPOT.TB performance in routine pediatric practice in a low TB burden setting","volume":"37","author":"Mandalakas","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2024072415162209600_B63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2018.04.034","article-title":"Interferon-gamma release assay-based screening for pediatric latent tuberculosis infection in an urban primary care network","volume":"200","author":"Gaensbauer","year":"2018","journal-title":"J Pediatr"},{"issue":"1","key":"2024072415162209600_B64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/INF.0000000000000494","article-title":"Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection","volume":"34","author":"Howley","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2024072415162209600_B65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tube.2017.12.005","article-title":"Utility of the T-SPOT\u00ae.TB test\u2019s borderline category to increase test resolution for results around the cut-off point","volume":"108","author":"Rego","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"2024072415162209600_B66","doi-asserted-by":"crossref","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"2024072415162209600_B67","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MPG.0000000000000205","article-title":"Disease activity is an important factor for indeterminate interferon-\u03b3 release assay results in children with inflammatory bowel disease","volume":"58","author":"Hradsky","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"2024072415162209600_B68","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thx.2009.127555","article-title":"A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children","volume":"65","author":"Lucas","year":"2010","journal-title":"Thorax"},{"issue":"5","key":"2024072415162209600_B69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jinf.2013.06.011","article-title":"QuantiFERON to diagnose infection by Mycobacterium tuberculosis: performance in infants and older children","volume":"67","author":"Blandini\u00e8res","year":"2013","journal-title":"J Infect"},{"issue":"5","key":"2024072415162209600_B70","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5588\/ijtld.10.0555","article-title":"QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact","volume":"15","author":"Kasambira","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024072415162209600_B71","doi-asserted-by":"crossref","unstructured":"Bergamini\n              BM\n            , LosiM, VaientiF, . Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics. 2009;123(3). Available at: www.pediatrics.org\/cgi\/content\/full\/123\/3\/e419","DOI":"10.1542\/peds.2008-1722"},{"issue":"4","key":"2024072415162209600_B72","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jpeds.2012.04.007","article-title":"The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection","volume":"161","author":"Critselis","year":"2012","journal-title":"J Pediatr"},{"key":"2024072415162209600_B73","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fped.2019.00208","article-title":"Risk factors for indeterminate interferon-gamma release assay for the diagnosis of tuberculosis in children-a systematic review and meta-analysis","volume":"7","author":"Meier","year":"2019","journal-title":"Front Pediatr"},{"issue":"3","key":"2024072415162209600_B74","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"2024072415162209600_B75","doi-asserted-by":"crossref","first-page":"e26827","DOI":"10.1371\/journal.pone.0026827","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"2024072415162209600_B76","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"2024072415162209600_B77","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/INF.0b013e31827d77b7","article-title":"Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction","volume":"32","author":"Mandalakas","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2024072415162209600_B78","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1097\/INF.0000000000001771","article-title":"Comparison of the QuantiFERON TB Gold In-tube assay with tuberculin skin test for the diagnosis of latent tuberculosis infection among HIV-infected and uninfected children","volume":"36","author":"Dehority","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2024072415162209600_B79","unstructured":"AIDSinfo\n          . Mycobacterium tuberculosis infection and disease. 2019. Available at: https:\/\/aidsinfo.nih.gov\/guidelines\/html\/4\/adult-and-adolescent- opportunistic-infection\/325\/mycobacterium-tuberculosis. Accessed June 15, 2020"},{"issue":"6","key":"2024072415162209600_B80","first-page":"689","article-title":"Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer","volume":"14","author":"Stefan","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"2024072415162209600_B81","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s15010-013-0450-y","article-title":"Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis","volume":"41","author":"Carvalho","year":"2013","journal-title":"Infection"},{"issue":"4","key":"2024072415162209600_B82","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/BOR.0b013e3283474d62","article-title":"Interferon-\u03b3 release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders","volume":"23","author":"Smith","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"2024072415162209600_B83","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2012-201979","article-title":"You can\u2019t always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need","volume":"71","author":"Winthrop","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2024072415162209600_B84","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12519-017-0050-5","article-title":"Performance of QuantiFERON\u00ae-TB Gold In-Tube assay in children receiving disease modifying anti-rheumatic drugs","volume":"13","author":"Gabriele","year":"2017","journal-title":"World J Pediatr"},{"issue":"12","key":"2024072415162209600_B85","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/CVI.05299-11","article-title":"Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy","volume":"18","author":"Vassilopoulos","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"2024072415162209600_B86","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5588\/ijtld.12.0111","article-title":"Screening for latent tuberculosis in anti-TNF-\u03b1 candidate patients in a high tuberculosis incidence setting","volume":"16","author":"Saidenberg-Kermanac\u2019h","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"2024072415162209600_B87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10067-012-1938-z","article-title":"Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment","volume":"31","author":"M\u00ednguez","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"10","key":"2024072415162209600_B88","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.5588\/ijtld.17.0883","article-title":"Contribution of the interferon-gamma release assay to tuberculosis diagnosis in children and adolescents","volume":"22","author":"Silveira","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"2024072415162209600_B89","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/INF.0b013e3182272227","article-title":"Interferon-gamma release assay performance for diagnosing tuberculosis disease in 0- to 5-year-old children","volume":"30","author":"Debord","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"2024072415162209600_B90","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.5588\/ijtld.10.0770","article-title":"Tuberculin skin test and QuantiFERON\u00ae assay in young children investigated for tuberculosis in South Africa","volume":"15","author":"Moyo","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"2024072415162209600_B91","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/INF.0b013e318220c52a","article-title":"Interferon-\u03b3 release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age","volume":"30","author":"Pavi\u0107","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2024072415162209600_B92","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/INF.0000000000002015","article-title":"Performance of tuberculin skin tests and interferon-\u03b3 release assays in children younger than 5 years","volume":"37","author":"Velasco-Arnaiz","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2024072415162209600_B93","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jpids\/piu119","article-title":"Interferon-gamma release assays and pediatric public health tuberculosis screening: the San Francisco Program Experience 2005 to 2008","volume":"5","author":"Grinsdale","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"2024072415162209600_B94","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"2024072415162209600_B95","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"2024072415162209600_B96","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/INF.0b013e318236984f","article-title":"Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy","volume":"31","author":"Cruz","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2024072415162209600_B97","unstructured":"Centers for Disease Control and Prevention\n          . Reported tuberculosis in the United States, 2018. 2019. Available at: www.cdc.gov\/tb\/statistics\/reports\/2018\/. Accessed June 19, 2020"},{"issue":"8","key":"2024072415162209600_B98","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/cid\/ciz491","article-title":"Rifampin-resistant Tuberculosis in the United States, 1998-2014","volume":"70","author":"Sharling","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"23","key":"2024072415162209600_B99","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2024072415162209600_B100","doi-asserted-by":"crossref","first-page":"e20172838","DOI":"10.1542\/peds.2017-2838","article-title":"Completion rate and safety of tuberculosis infection treatment with shorter regimens","volume":"141","author":"Cruz","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"2024072415162209600_B101","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"Horsburgh","year":"2010","journal-title":"Chest"},{"issue":"39","key":"2024072415162209600_B102","first-page":"805","article-title":"Transmission of Mycobacterium tuberculosis in a high school and school-based supervision of an isoniazid-rifapentine regimen for preventing tuberculosis - Colorado, 2011-2012","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2024072415162209600_B103","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"issue":"10","key":"2024072415162209600_B104","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3201\/eid2410.180459","article-title":"Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA","volume":"24","author":"Garfein","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"10177","key":"2024072415162209600_B105","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(18)32993-3","article-title":"Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial","volume":"393","author":"Story","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"2024072415162209600_B106","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jpids\/pit030","article-title":"Treatment of latent tuberculosis infection in children","volume":"2","author":"Cruz","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"2024072415162209600_B107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2024072415162209600_B108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"25","key":"2024072415162209600_B109","doi-asserted-by":"crossref","first-page":"723","DOI":"10.15585\/mmwr.mm6725a5","article-title":"Update of recommendations for use of once-weekly isoniazid-rifapentine regimen to treat latent Mycobacterium tuberculosis infection","volume":"67","author":"Borisov","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2024072415162209600_B110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.5588\/ijtld.14.0286","article-title":"Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children","volume":"18","author":"Cruz","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"2024072415162209600_B111","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1714284","article-title":"Safety and side effects of rifampin versus isoniazid in children","volume":"379","author":"Diallo","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"2024072415162209600_B112","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/INF.0000000000001721","article-title":"Better completion of pediatric latent tuberculosis treatment using 4 months of rifampin in a US-based tuberculosis clinic","volume":"37","author":"Gaensbauer","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"2024072415162209600_B113","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/archdischild-2013-303876","article-title":"Question 1: what are the options for treating latent TB infection in children?","volume":"98","author":"Gwee","year":"2013","journal-title":"Arch Dis Child"},{"key":"2024072415162209600_B114","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"issue":"7","key":"2024072415162209600_B115","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2024072415162209600_B116","first-page":"806","article-title":"Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis","volume":"14","author":"Lin","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"2024072415162209600_B117","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline","volume":"200","author":"Nahid","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2024072415162209600_B118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"2024072415162209600_B119","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-054663\/1677641\/peds_2021054663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-054663\/1677641\/peds_2021054663.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:19:06Z","timestamp":1721827146000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/148\/6\/e2021054663\/183445\/Tuberculosis-Infection-in-Children-and-Adolescents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-054663","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"article-number":"e2021054663"}}